e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Lung cancer therapy: clinical trials
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical and therapeutic characteristics of patients died due to radiation-induced pneumonitis
David Angel Yabar Bedoya (Barcelona, Spain), David Yabar, Arturo Navarro, Susana Padrones, Ramón Palmero, Jordi Dorca, Samantha Aso
Source:
International Congress 2015 – Lung cancer therapy: clinical trials
Session:
Lung cancer therapy: clinical trials
Session type:
Poster Discussion
Number:
4835
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
David Angel Yabar Bedoya (Barcelona, Spain), David Yabar, Arturo Navarro, Susana Padrones, Ramón Palmero, Jordi Dorca, Samantha Aso. Clinical and therapeutic characteristics of patients died due to radiation-induced pneumonitis. Eur Respir J 2015; 46: Suppl. 59, 4835
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
General characteristics and therapeutic options in lung cancer in Turkey
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Sclerosing hemangioma of the lung: Report of 4 cases
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
PET-CT predictors of mediastinal dissemination in lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014
A rare cause of cavitary lesion in the lung: Richter’s transformation
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Survival in lung cancer: Associated factors in Tunisian patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Clinicopathological characteristics and treatment outcomes of pulmonary carcinosarcoma in eight patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Outcome of patients with non specific pleuritis after medical thoracoscopy
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Single-institution experience of the combined operations in management of lung cancer: Lessons learned
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Pulmonary artery sarcoma. Complex problems with a rare tumor
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis?
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Diagnosing lung cancer: Choosing the best for your patient
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014
Occult foreign bodies mimicking lung cancer: A rare entity
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept